Faron Pharmaceuticals Oy (GB:FARN)

Faron Pharmaceuticals Oy (FARN) Financial Statements


Faron Pharmaceuticals Oy Financial Overview

Faron Pharmaceuticals Oy's market cap is currently ―. The company's EPS TTM is p-0.341; its P/E ratio is -4.09; Faron Pharmaceuticals Oy is scheduled to report earnings on August 27, 2024, and the estimated EPS forecast is p-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 6.99M€ 9.94M€ 6.85M€ 6.97M€ 4.11M
Total Assets€ 11.27M€ 16.73M€ 13.18M€ 11.87M€ 8.37M
Total Debt€ 13.27M€ 12.36M€ 3.55M€ 3.52M€ 3.23M
Net Debt€ 6.28M€ 2.42M€ -3.31M€ -3.45M€ -883.00K
Total Liabilities€ 22.75M€ 21.92M€ 10.26M€ 9.05M€ 10.22M
Stockholders Equity€ -11.48M€ -5.19M€ 2.92M€ 2.81M€ -1.85M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

Faron Pharmaceuticals Oy Earnings and Revenue History

Faron Pharmaceuticals Oy Debt to Assets

Faron Pharmaceuticals Oy Cash Flow

Faron Pharmaceuticals Oy Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis